Industry Overview
Diagnostic kits and in-vitro diagnostic devices (IVDs) are increasingly used to identify communicable diseases, including transfusion-transmissible infections. Inadequate or absent regulatory systems can result in the uncontrolled use and international movement of IVDs, potentially contributing to inaccurate diagnoses, transmission of infections through blood transfusion, and unreliable epidemiological information.
A comprehensive national policy and regulatory mechanism is essential to ensure that only quality IVDs reach users. The National Regulatory Authority (NRA) should hold the legal responsibility for assuring IVD quality, supported by an independent National Reference or Regulatory Laboratory (NRL) providing technical assistance, pre-market evaluation, and post-market surveillance. Existing pharmaceutical regulatory frameworks in South-East Asia can provide a foundation for developing IVD quality-assurance policies.
Private-sector healthcare delivery is expanding in many low- and middle-income countries, creating opportunities for broader diagnostic service delivery models. PATH has examined private-sector approaches, particularly in India, to support the introduction and scale-up of diagnostic technologies. Modern diagnostic centres can provide comprehensive pathological, radiological, cardiological, neurological, gynecological, and other diagnostic services using specialized equipment and healthcare professionals. The sector therefore encompasses diagnostic reagents and kits, laboratory infrastructure, regulatory compliance, quality systems, manufacturing, and diverse diagnostic services.
Cost Estimation
| Particulars | Value |
|---|---|
| Plant Capacity | 500 Nos/Day |
| Land & Building | (600 sq.mt.) |
| Plant & Machinery | US$.64285 |
| Rate of Return | 37% |
| Beak Even Point | 50% |
Content Index
- INTRODUCTION
- ROLE OF VARIOUS ORGANIZATIONAL GROUPS FOR DIAGNOSTIC REAGENT
- THE GOVERNMENT
- NATIONAL REGULATORY AUTHORITY
- NATIONAL REGULATORY LABORATORY
- REGIONAL AND DISTRICT LABORATORIES
- REQUIREMENTS FROM MANUFACTURERS FOR EVALUATION OF IN-VITRO DIAGNOSTICS
- QUALITY SYSTEM
- THE APPLICATION MUST INCLUDE:
- GENERAL REQUIREMENTS FOR ELISA-BASED KITS FOR DETECTION OF HBS AG,ANTIBODIES TO HIV AND HCV.
- QUALITY REQUIREMENTS FOR RAPID KITS FOR HIV, HBV AND HCV
- GUIDELINES AND IMPLEMENTATION OF DIAGNOSTIC REAGENT & KIT
- LAW AND POLICY
- NATIONAL REGULATORY AUTHORITY
- NATIONAL REFERENCE LABORATORY
- NETWORKING
- GOOD MANUFACTURING PRACTICES
- SETTING UP A DIAGNOSTIC LAB IN INDIA
- SPACE
- FINANCE
- INSTRUMENTS
- STAFF
- LICENSE/ REGISTRATION
- MEDICAL KNOWLEDGE
- OVERVIEW OF DIAGNOSTIC LAB IN INDIA
- OPPORTUNITIES IN THE DIAGNOSTICS LABORATORY
- BENEFITS OF CRM IN THE DIAGNOSTICS SECTOR:
- SURGING AHEAD
- MARKET OVERVIEW OF DIAGNOSTIC REAGENTS
- THE TOP MAJOR COMPANIES IN DIAGNOSTIC REAGENTS MARKET ARE:
- SCENARIO OF HEALTHCARE IN INDIA
- FIGURE: HEALTHCARE PYRAMID
- FIGURE: PRIMARY CARE
- FIGURE: DISTRIBUTION OF DEATHS BY MAJOR CAUSE, INDIA (SOURCE: SPECIAL SURVEY OF DEATHS, REGISTRAR GENERAL OF INDIA)
- FIGURE: CAUSES OF DEATH IN URBAN AREAS (25 – 69 YRS. OF AGE AS %)
- CARDIOVASCULAR DISEASES CONSTITUTE THE LARGEST SEGMENT (SOURCE: SPECIAL SURVEY OF DEATHS, REGISTRAR GENERAL OF INDIA)
- FIGURE: CAUSES OF DEATH IN RURAL AREAS (25 – 69 YRS. OF AGE AS %)
- CARDIOVASCULAR DISEASES CONSTITUTE THE LARGEST SEGMENT (SOURCE: SPECIAL SURVEY OF DEATHS, REGISTRAR GENERAL OF INDIA)
- MARKET OVERVIEW OF DIEGNOSTIC INDUSTRY
- BUSINESS MODELS
- BUSINESS STRATEGIES
- INTEREST IN NEW AND INNOVATIVE TECHNOLOGIES
- POTENTIAL FOR COLLABORATION WITH PATH
- RECOMMENDATIONS
- GUIDELINES FOR REAGENT MANUFACTURE
- RISK MANAGEMENT
- PERFORMANCE EVALUATION
- STABILITY DATA
- DATE OF MANUFACTURE
- COLOUR CODING OF REAGENTS
- FREEDOM FROM MICROBIAL CONTAMINANTS
- RETAINED SAMPLES
- TESTS REQUIRED
- HUMAN SOURCE MATERIAL
- LABEL REQUIREMENTS
- LABEL COLOUR CODING
- FORMULATION AND MANUFACTURING PROCESS OF DIAGNOSTIC REAGENT
- EXAMPLE 1
- EXAMPLE 2
- EXAMPLE 3
- CLAIMS
- PREPARATION OF COMMON REAGENT SOLUTION
- TABLE PREPARATION OF SOLUTIONS WITH DEFINED HCL CONCENTRATION
- THE USE OF REFERENCE BUFFERS AND THEIR PURPOSE
- PREPARATION OF REFERENCE BUFFERS
- POTASSIUM SODIUM PHOSPHATE BUFFER (39,125 MMOL/L)
- MIX WELL BY SHAKING
- CALIBRATION OF VOLUMETRIC PIPETTES AND FLASKS (GRAVIMETRIC PROCEDURE)
- PROFILES OF EXISTING DIAGNOSTIC LABORATORIES
- PLANT LAYOUT
- SUPPLIERS OF PLANT AND MACHINERY
Appendix
- APPENDIX – A:
- 01. PLANT ECONOMICS
- 02. LAND & BUILDING
- 03. PLANT AND MACHINERY
- 04. OTHER FIXED ASSESTS
- 05. FIXED CAPITAL
- 06. RAW MATERIAL
- 07. SALARY AND WAGES
- 08. UTILITIES AND OVERHEADS
- 09. TOTAL WORKING CAPITAL
- 10. TOTAL CAPITAL INVESTMENT
- 11. COST OF PRODUCTION
- 12. TURN OVER/ANNUM
- 13. BREAK EVEN POINT
- 14. RESOURCES FOR FINANCE
- 15. INSTALMENT PAYABLE IN 5 YEARS
- 16. DEPRECIATION CHART FOR 5 YEARS
- 17. PROFIT ANALYSIS FOR 5 YEARS
- 18. PROJECTED BALANCE SHEET FOR (5 YEARS)
Frequently Asked Questions
Diagnostic reagents and in-vitro diagnostic devices are products used to examine biological samples and support the detection, diagnosis, monitoring, or assessment of diseases.
IVDs include diagnostic kits, reagents, and associated systems used outside the human body. They can support testing for communicable diseases, blood-transfusion-related infections, and numerous other medical conditions. Their quality, performance, manufacturing controls, labeling, stability, and appropriate evaluation are important because test results can directly influence clinical decisions and epidemiological information.
Regulatory control helps ensure that diagnostic reagents and IVDs meet defined requirements for quality, safety, and performance.
Without adequate regulatory oversight, inappropriate or poorly performing diagnostic products may enter the market and produce inaccurate results. A national regulatory framework can establish requirements for manufacturers, product evaluation, quality systems, labeling, manufacturing practices, and post-market surveillance. Such controls are particularly important for diagnostic products used in blood screening and infectious-disease testing, where unreliable results can have significant consequences.
The National Regulatory Authority provides the legal and regulatory framework for assuring the quality of IVDs.
Its responsibilities can include establishing regulatory requirements, evaluating products before marketing, overseeing manufacturers and importers, and supporting post-market surveillance. The authority operates within the applicable legislative framework and works with technical and laboratory institutions where necessary. Effective regulation helps create a controlled pathway for diagnostic products while supporting consistent quality and appropriate use in healthcare settings.
A National Reference Laboratory provides independent technical and scientific support for the regulatory system governing IVDs.
The report describes the NRL as supporting the National Regulatory Authority through comprehensive quality-assurance activities. These may include technical evaluation of diagnostic products before marketing and post-market surveillance. Maintaining an appropriate degree of independence from the regulatory authority is important for credible technical assessment. Reference laboratory networks can also contribute to consistent testing practices, technical guidance, and quality assurance across diagnostic facilities.
A modern diagnostic centre generally requires suitable space, diagnostic instruments, qualified staff, regulatory registrations, and appropriate medical expertise.
The report identifies a broad range of diagnostic activities, including pathological testing, X-rays, ultrasound, electrocardiography, electroencephalography, IVP, gynecological and endoscopic examinations, blood-pressure testing, tuberculosis-related testing, pregnancy testing, and cardiological investigations. Depending on the services offered, centres may also require specialists such as pathologists, radiologists, cardiologists, neurologists, endocrinologists, ENT specialists, ophthalmologists, and orthopaedic specialists.
Diagnostic reagent manufacturing requires controlled processes, quality systems, performance evaluation, stability assessment, contamination control, and appropriate labeling.
The report covers risk management, performance evaluation, stability data, manufacturing dates, colour coding, retained samples, required testing, human-source materials, and label requirements. Good manufacturing practices and documented procedures help maintain product consistency. Appropriate reference materials, calibrated volumetric equipment, controlled reagent preparation, and defined manufacturing procedures can further support reliable production and testing outcomes.
Why Choose Us
- More than 45 years of experience
- Managed by expert industrial consultants
- ISO 9001-2015 Certified
- Registered under MSME, UAM No: DL01E0012000
How We Work
- 24/5 Research Support Get your queries resolved from an industry expert. Ask before you purchase.
- Custom Research Service Speak to our consultants to design an exclusive study for your needs.
- Quality Assurance All reports are prepared by qualified consultants & verified by experts.
- Information Security Your personal & confidential information is always safe and secure.
Detailed Project Report (DPR) includes Present Market Position and Expected Future Demand, Technology, Manufacturing Process, Investment Opportunity, Plant Economics and Project Financials. comprehensive analysis from industry covering detailed reporting and evaluates the position of the industry by providing insights to the SWOT analysis of the industry.
Each report include Plant Capacity, requirement of Land & Building, Plant & Machinery, Flow Sheet Diagram, Raw Materials detail with suppliers list, Total Capital Investment along with detailed calculation on Rate of Return, Break-Even Analysis and Profitability Analysis. The report also provides a birds eye view of the global industry with details on projected market size and then progresses to evaluate the industry in detail.
We can prepare detailed project report on any industry as per your requirement.
We can also modify the project capacity and project cost as per your requirement. If you are planning to start a business, contact us today.
- Market growth drivers
- Factors limiting market growth
- Current market trends
- Market structure
- Key highlights
- Up-to-date analyses of market trends and technological improvements
- Pin-point analyses of market competition dynamics to offer you a competitive edge over major competitors
- An array of graphics, BEP analysis of major industry segments
- Detailed analyses of industry trends
- A well-defined technological growth with an impact-analysis
- A clear understanding of the competitive landscape and key product segments
- Ask for FREE project related details with our consultant/industry expert.
- Share your specific research requirements for customized project report.
- Request for due diligence and consumer centric studies.
- Still haven't found what you're looking for? Speak to our Custom Research Team.
EIRI Board is a single destination for all the industry, company and country reports. We feature a large repository of latest industry reports, leading and niche company profiles, and market statistics prepared by highly qualified consultants and verified by a panel of experts.
Note: We can also prepare project report on any subject based on your requirement and country. If you need, we can modify the project capacity and project cost based on your requirement.
Our reports provide an expansive market analysis of the sector by covering areas like growth drivers, trends prevailing in the industry as well as comprehensive SWOT analysis of the sector.
Our Clients
- Our research reports comprehensively cover Indian markets (can be modified as per your country), present investigation, standpoint and gauge for a time of five years*.
- The market conjectures are produced on the premise of optional research and are cross-accepted through associations with the business players.
- We use dependable wellsprings of data and databases, and data from such sources is handled by us and incorporated into the report.
- Our project reports include detailed analysis that helps get the industry's Present Market Position and Expected Future Demand.
- Offer real analysis driving variables for the business and the most recent business sector patterns in the industry.
- This report comprehends the present status of the business by clarifying a complete SWOT examination and investigation of the interest-supply circumstance.
- Report gives analysis and in-depth financial comparison of real players/competitors.
- The report gives estimates of key parameters which forecast business execution.
